Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
HeartSciences Inc. - Common Stock
(NQ:
HSCS
)
2.900
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
143
Open
2.900
Bid (Size)
2.810 (4)
Ask (Size)
2.900 (1)
Prev. Close
2.900
Today's Range
2.900 - 2.900
52wk Range
2.360 - 26.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
November 13, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
Performance
YTD
-82.66%
-82.66%
1 Month
-3.01%
-3.01%
3 Month
-10.49%
-10.49%
6 Month
-57.42%
-57.42%
1 Year
-88.54%
-88.54%
More News
Read More
Recap: Heart Test Laboratories Q3 Earnings
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 11, 2024
Via
Benzinga
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket
September 24, 2024
Via
Benzinga
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
September 12, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
September 12, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
July 29, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
July 26, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
July 25, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 11, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
HeartSciences Regains Compliance with Nasdaq Listing Requirements
June 04, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
May 20, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 17, 2024
Via
Benzinga
US Stocks Edge Higher; Applied Materials Posts Upbeat Earnings
May 17, 2024
Via
Benzinga
Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 13, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 25, 2024
Via
Benzinga
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
April 24, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences to Present at the LD Micro Invitational XIV Conference
April 02, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
March 26, 2024
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024
March 14, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.